Investigates the role of AaaA in chronic wounds, highlighting its importance in biofilm formation.
Pseudomonas aeruginosa is commonly isolated from chronic wounds where it forms biofilms that are recalcitrant to current treatments, greatly impacting the morbidity and mortality of infected patients. Since P. aeruginosa dictates wound severity and treatment outcomes, this bacterium is an important target in the treatment of chronic wound infections. This study aimed to unravel the functional intricacies of a key virulence factor, the arginine-specific aminopeptidase of P. aeruginosa (AaaA), which is crucial for the establishment and persistence of chronic infections. While interrogation of genomes revealed that aaaA is highly conserved, its activity varied between chronic wound clinical isolates. To explore the phenotypic impact of AaaA in chronic infections, a collagen-based synthetic chronic wound (SCW) model was optimized to enable reproducible assessment of AaaA activity. AaaA activity was increased within the SCW compared to planktonic cultures, further supporting the hypothesis that this virulence factor is integral to chronic infections caused by P. aeruginosa . It was also shown that AaaA contributed to biofilm formation as well as providing a survival advantage within the SCW model. Overall, a novel link between AaaA and biofilm formation was verified and served to guide the optimisation of a realistic chronic wound infection model.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: